ArticleJournal of Korean medical science2023

Nationwide Treatment Outcomes of Patients With Multidrug/Rifampin-Resistant Tuberculosis in Korea, 2011-2017: A Retrospective Cohort Study (Korean TB-POST).

Hongjo Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.